Skip to main content
Clinical Trials/NCT03650777
NCT03650777CompletedNot Applicable

Impact of Telehealth Warfarin Education on Patient Retention

Baylor Research Institute0 sites18 target enrollmentStarted: February 18, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Primary Endpoint
Long Term Knowledge Retention of warfarin education post video watching

Study Overview

Brief Summary

The objective of this study is to evaluate the effectiveness of telehealth warfarin education in a charity outpatient clinic. The purpose is to increase patient knowledge with regard to their warfarin therapy and to measure knowledge retention

Detailed Description

  1. This study is conducted in outpatient ambulatory care clinics at the Baylor Family Medicine Worth Street clinic and the Irving Interfaith clinic. The average census for warfarin patients Friday clinic is 10. The anticoagulation clinic consists of an interdisciplinary team including physicians, medical assistants, nurse practitioners, and pharmacists. Patients initially visit with the provider and subsequent follow up INR checks are performed by the pharmacists or medical assistants. Currently, pharmacists manage the anticoagulation clinic on Fridays and medical assistants manage the clinic on Monday through Thursday. All providers provide patient education through written brochures.

  2. Study Design

a. This study is a prospective, single-centered, randomized controlled quality improvement pilot study.

  1. Warfarin Education Procedures

  2. Each Friday morning, the pharmacist will identify the patients with appointments for INR checks.

  3. As each patient checks in for their appointment, the pharmacist will ask the patient for consent to be a part of the study

  4. If the patient says yes, the pharmacist will have the patient complete a warfarin questionnaire and health literacy test to see the patient's baseline knowledge on their warfarin therapy

  5. Intervention patients (iPAD® video)

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age > 18 years
  • English as a first language
  • Currently taking warfarin for an approved indication
  • Having the ability to see, read, and hear for verbal, written, and iPad® warfarin education

Exclusion Criteria

  • Age < 18 years
  • Unwilling to receive iPad counseling
  • Cognitive dysfunction and impairments that prevents patient from fully comprehending warfarin education

Outcomes

Primary Outcomes

Long Term Knowledge Retention of warfarin education post video watching

Time Frame: initial and follow up visit (max 30 days)

Difference in pre video test and follow up retention test for warfarin education in patients receiving warfarin education via iPad

Knowledge Retention of Warfarin Education post video watching

Time Frame: pre and post video test(20 minutes)

Difference in pre warfarin education video and post video test for warfarin education in patients receiving warfarin education via iPad

Secondary Outcomes

  • Self Reported Adherence to Warfarin therapy during duration of study(Between initial and follow up visit ( max 30 days))
  • Satisfaction Survey(Max 30 days)
  • Adverse Events(Between initial and follow up visit ( max 30 days))
  • Time of Warfarin in Therapeutic Range for Duration of Study(Between initial and follow up visit ( max 30 days))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials